Despite Pandemic's Toll, Many Older Adults Don't Have Living Wills

Title: Despite Pandemic's Toll, Many Older Adults Don't Have Living WillsCategory: Health NewsCreated: 4/8/2021 12:00:00 AMLast Editorial Review: 4/8/2021 12:00:00 AM
Source: MedicineNet Senior Health General - Category: Geriatrics Source Type: news

Related Links:

Source: Rheumatology International - Category: Rheumatology Source Type: research
AbstractAs the most well-known and popular video-sharing platform around the world, YouTube is an influential tool for the dissemination of health-related information. In addition, considering the increase in obtaining information from internet-based sources in pandemic conditions, YouTube has become more important in the presentation of information related to COVID-19. Therefore, the aim of this study was to evaluate videos related to COVID-19 vaccination in rheumatic diseases (RD) on YouTube. In this descriptive study, 334 video URLs listed with six search terms were recorded (26 July 2021). Three quality groups (high, i...
Source: Rheumatology International - Category: Rheumatology Source Type: research
This study included 1430 retrieved articles with open access mostly. The top five journals in this field were Annals of the Rheumatic Diseases (n = 65), Rheumatology International (n = 51), Clinical Rheumatology (n = 50), Lancet Rheumatology (n = 50), and Frontiers In Immunology (n = 33). Most studies originate from countries with a high incidence of COVID-19 among the general population (the USA—387; Italy—268; UK—184; France—114; Germany—110; India—98 and Spain—96, China—94, Canada—73 Turkey—6...
Source: Rheumatology International - Category: Rheumatology Source Type: research
p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a{ padding:0; } img{ -ms-interpolation-mode:bicubic; } table{ mso-table-lspace:0pt; mso-table-rspace:0pt; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } p,a,li,td,blockquote{ m...
Source: Johns Hopkins University and Health Systems Archive - Category: Nursing Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
They ministers agreed to increase budgetary and human resource allocations including upfront investments required to catch-up on lost ground during the COVID-19 pandemic. It is estimated that $3 billion may be needed annually to implement comprehensive set of interventions required to end TB in the Region.
Source: The Economic Times - Category: Consumer Health News Source Type: news
The European Union's drug regulator is beginning to review Merck's antiviral COVID-19 drug. The drug has been called a potential 'game-changer' for the pandemic as the first oral pill for Covid.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Louisiana is ending its statewide indoor mask mandate after emerging from its latest and worst coronavirus spike of the pandemic and seeing a sharp decline in new COVID-19 infections
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
“As the next wave of the pandemic unfolds, the rise in cases is once again straining health care systems. But that ’s not the only reason hospitals and health systems could experience an influx of emergency or critical care visits. Findings from the National Poll on Healthy Aging based at the University of Michigan Institute forRead more …Why now is the time to get patients back to in-person routine care [PODCAST] originally appeared
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Podcast Primary Care Source Type: blogs
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11. In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the youngest group yet to potentially get immunized against the disease in the US. The committee recommended a two-dose regimen at one-third the dosage approved for adults. The FDA now takes the committee’s advice into consideration before making a final recommendation. If the agency decides to recommend th...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Geriatrics | Pandemics